A round-up of the latest HIV news, for people living with HIV in the UK and beyond.
Welcome to HIV Weekly, an email bulletin that will provide people with, or affected by, HIV with a concise, plain English digest of a selection of the very latest HIV news.
This new digest puts the latest HIV news stories into their context to equip you with the knowledge to understand what the latest research might mean for your HIV treatment and care.
Information on the latest NAM treatment information resources and those produced by other key organisations such as the UK Coalition and THT are also included.
HIV Weekly is edited by Michael Carter, NAM's patient information and news editor.
There are five broad sections this week:
- HIV treatment –Kaletra monotherapy, good results for tipranavir and people may be more willing to take T-20 than their doctors think.
- Side-effects – what causes bone problems in people with HIV, drugs or HIV itself? Tenofovir doesn’t cause bone problems in kids. Study suggests Il-2 side-effects short lived and that treatment with it has benefits.
- HIV and cancer – the rate of anal cancer has increased since effective HIV treatment became available, but people are living longer with it.
- HIV and hepatitis – treatment for early hepatitis C virus infection effective in people with HIV, and deaths from liver disease (mainly due to hepatitis B and/or C) have increased in Europe since effective HIV treatment was introduced.
- HIV prevention – some people with drug-resistant HIV having unprotected sex, and number of gay men having unprotected sex in London stabilises.